BioSig Technologies, Inc.
  • Home
  • About BioSig
    • Overview
    • Leadership
    • Partnerships
  • PURE EP
    • Our Solution
    • Publications
    • Physician Insights
  • Join Our Team
  • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Presentations
    • Events
    • Newsletter
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Fact Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Achieves First Commercial Sale of Three PURE EP Systems

December 11, 2020

BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event Conference

December 10, 2020

BioSig to Highlight PURE EP™ System at the Benzinga Global Small Cap Conference

December 3, 2020

BioSig’s PURE EP System to Support Live Patient Cases during EPLive 2020

November 30, 2020

BioSig to Host Business Update Conference Call on November 18, 2020

November 12, 2020

BioSig Announces Completion of PURE EP™ System Installation at New Medical Center

October 29, 2020

BioSig Issues October 2020 Shareholder Update Letter

October 28, 2020

ViralClear halts its Phase 2 Hospitalized COVID-19 Trial

October 26, 2020

SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19

September 30, 2020

ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution

September 22, 2020
rss_feed News RSS
  • Previous
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...32
    Next
    Award
    BioSig Technologies, Inc.
    Sign Up for BioSig Updates Contact Us
    Twitter linkedin Facebook
    © 2023 BioSig Technologies, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap